ImportRefusal LogoImportRefusal

Wuhan Wuyao Pharmaceutical Co.

⚠️ Moderate Risk

FEI: 3014015153 • Wuhan, Hubei • CHINA

FEI

FEI Number

3014015153

📍

Location

Wuhan, Hubei

🇨🇳

Country

CHINA
🏢

Address

No 5 Gutian Road, , Wuhan, Hubei, China

Moderate Risk

FDA Import Risk Assessment

38.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
4
Unique Violations
1/24/2012
Latest Refusal
3/18/2010
Earliest Refusal

Score Breakdown

Violation Severity
76.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
16.2×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

Refusal History

DateProductViolationsDivision
1/24/2012
62QOR03AUROTHIOGLUCOSE (ANTI-RHEUMATIC)
16DIRECTIONS
72NEW VET DR
Chicago District Office (CHI-DO)
3/18/2010
60CAS04EPINEPHRINE (ADRENERGIC)
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/18/2010
60CAS53XYLOMETAZOLINE HCL (ADRENERGIC)
75UNAPPROVED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Wuhan Wuyao Pharmaceutical Co.'s FDA import refusal history?

Wuhan Wuyao Pharmaceutical Co. (FEI: 3014015153) has 3 FDA import refusal record(s) in our database, spanning from 3/18/2010 to 1/24/2012.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Wuhan Wuyao Pharmaceutical Co.'s FEI number is 3014015153.

What types of violations has Wuhan Wuyao Pharmaceutical Co. received?

Wuhan Wuyao Pharmaceutical Co. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Wuhan Wuyao Pharmaceutical Co. come from?

All FDA import refusal data for Wuhan Wuyao Pharmaceutical Co. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.